FR2434622A1 - Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer - Google Patents

Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer

Info

Publication number
FR2434622A1
FR2434622A1 FR7921975A FR7921975A FR2434622A1 FR 2434622 A1 FR2434622 A1 FR 2434622A1 FR 7921975 A FR7921975 A FR 7921975A FR 7921975 A FR7921975 A FR 7921975A FR 2434622 A1 FR2434622 A1 FR 2434622A1
Authority
FR
France
Prior art keywords
cancer patients
feeding
amino acid
acid solutions
solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7921975A
Other languages
English (en)
French (fr)
Other versions
FR2434622B1 (enrdf_load_html_response
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR2434622A1 publication Critical patent/FR2434622A1/fr
Application granted granted Critical
Publication of FR2434622B1 publication Critical patent/FR2434622B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7921975A 1978-09-04 1979-09-03 Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer Granted FR2434622A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (2)

Publication Number Publication Date
FR2434622A1 true FR2434622A1 (fr) 1980-03-28
FR2434622B1 FR2434622B1 (enrdf_load_html_response) 1983-04-15

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7921975A Granted FR2434622A1 (fr) 1978-09-04 1979-09-03 Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer

Country Status (10)

Country Link
JP (1) JPS5535049A (enrdf_load_html_response)
AU (1) AU526207B2 (enrdf_load_html_response)
CA (1) CA1134275A (enrdf_load_html_response)
CH (1) CH642541A5 (enrdf_load_html_response)
DE (1) DE2935709C2 (enrdf_load_html_response)
FR (1) FR2434622A1 (enrdf_load_html_response)
GB (1) GB2029220B (enrdf_load_html_response)
IT (1) IT1194844B (enrdf_load_html_response)
NL (1) NL190266C (enrdf_load_html_response)
SE (1) SE448679B (enrdf_load_html_response)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591893A1 (fr) * 1985-12-19 1987-06-26 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982003552A1 (en) * 1981-04-17 1982-10-28 Hospital Supply Corp American Improved solution for parenteral nutrition
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
DE3329253A1 (de) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
WO1993006834A1 (fr) * 1991-10-07 1993-04-15 Otsuka Pharmaceutical Factory, Inc. Preparation enterique destinee au traitement du cancer
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
DE4228897A1 (de) * 1992-08-29 1994-03-03 Wella Ag Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
JP2930723B2 (ja) * 1992-11-19 1999-08-03 アンティキャンサー インコーポレーテド 抗メチオニン化学療法における抗腫瘍薬としてのメチオニナーゼの使用
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
RU2125874C1 (ru) * 1994-07-04 1999-02-10 Казанский государственный университет им.В.И.Ульянова-Ленина Композиция аминокислот с микроэлементами, обладающая противоопухолевой и антигипоксической активностью
AU716906B2 (en) * 1996-07-30 2000-03-09 Novartis Nutrition Ag Amino acid composition and use thereof in treating tumor growth and metastasis
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
RU2144821C1 (ru) * 1999-02-16 2000-01-27 Товарищество с ограниченной ответственностью Фирма "ГЛЕС" Противоопухолевое средство
EP1163904B1 (en) * 2000-06-16 2006-04-19 Rath, Matthias, Dr. med. Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium
EP1195159B1 (en) * 2000-10-09 2006-05-31 Rath, Matthias, Dr. med. Therapeutic combination of ascorbate with lysine and arginine for prevention and treatment of cancer
US6974833B2 (en) 2001-01-16 2005-12-13 Matthias Rath Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
JPWO2003030890A1 (ja) * 2001-10-05 2005-02-10 哲朗 浅尾 免疫系活性化剤
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
US20070258969A1 (en) * 2004-03-19 2007-11-08 Eliezer Zomer Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
UA94713C2 (uk) 2005-07-29 2011-06-10 Тіма Фондейшн Композиція для стримування метаболізму алкоголю та для зменшення ризику спричинених алкоголем захворювань
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
WO2007016955A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Alcohol metabolism moderating composition
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
PL2156188T3 (pl) 2007-03-28 2021-11-15 University Of Southern California Indukcja zróżnicowanej odporności na stres i jej zastosowania
JP2011523626A (ja) 2008-04-24 2011-08-18 ユニバーシティー オブ サウザン カリフォルニア，ユーエスシー スティーブンズ 化学療法、放射線療法、酸化ストレス、および加齢を防御するための食事組成物ならびに方法
TWI551288B (zh) * 2011-02-17 2016-10-01 Ea Pharma Co Ltd Antimicrobial activity enhancer for chemotherapeutic agents
JP2016117702A (ja) * 2014-12-22 2016-06-30 武輝 山田 ガン細胞の死滅法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
KR20200039748A (ko) 2017-08-14 2020-04-16 악셀라 헬스 인크. 간 질환 치료를 위한 아미노산 조성물
WO2019246225A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2008137A1 (enrdf_load_html_response) * 1968-05-09 1970-01-16 Astra Ab
DE2013026A1 (en) * 1970-03-19 1971-10-07 Wagner, Karl Heinz, Dr med habil Prof, 63O0Giessen Amino acid compsn against liver diseases
FR2316933A1 (fr) * 1975-07-07 1977-02-04 Fresenius Chem Pharm Ind Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU423304A3 (enrdf_load_html_response) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2531204C2 (de) * 1975-07-12 1987-01-22 Fresenius AG, 6380 Bad Homburg L-Aminosäuregemische für die parenterale oder orale Ernährung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2008137A1 (enrdf_load_html_response) * 1968-05-09 1970-01-16 Astra Ab
DE2013026A1 (en) * 1970-03-19 1971-10-07 Wagner, Karl Heinz, Dr med habil Prof, 63O0Giessen Amino acid compsn against liver diseases
FR2316933A1 (fr) * 1975-07-07 1977-02-04 Fresenius Chem Pharm Ind Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales.

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1959 *
CA1970 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591893A1 (fr) * 1985-12-19 1987-06-26 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
WO1987003810A1 (fr) * 1985-12-19 1987-07-02 Centre National De La Recherche Scientifique (Cnrs Compositions nutritionnelles carencees en methionine et supplementee en homocysteine
EP0232652A1 (fr) * 1985-12-19 1987-08-19 Centre National De La Recherche Scientifique (Cnrs) Compositions nutritionnelles carencées en méthionine et supplémentées en homocystéine

Also Published As

Publication number Publication date
NL190266B (nl) 1993-08-02
NL190266C (nl) 1994-01-03
IT7905216A0 (it) 1979-09-03
CA1134275A (en) 1982-10-26
AU526207B2 (en) 1982-12-23
DE2935709C2 (de) 1986-02-06
CH642541A5 (de) 1984-04-30
GB2029220A (en) 1980-03-19
JPS5535049A (en) 1980-03-11
GB2029220B (en) 1983-03-30
SE7907316L (sv) 1980-03-05
JPS6154007B2 (enrdf_load_html_response) 1986-11-20
DE2935709A1 (de) 1980-03-13
SE448679B (sv) 1987-03-16
FR2434622B1 (enrdf_load_html_response) 1983-04-15
IT1194844B (it) 1988-09-28
NL7906620A (nl) 1980-03-06
AU5036879A (en) 1980-03-13

Similar Documents

Publication Publication Date Title
FR2434622A1 (fr) Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer
ATE213389T1 (de) Antemortem futterzusatz für lebendes vieh
BE1002296A5 (fr) Derives peptidiques.
DK0751769T3 (da) Medicinsk behandling under anvendelse af skjoldbruskhormoner
SE9403526D0 (sv) New Peptides
FR2618331B1 (fr) Compositions pharmaceutiques utiles pour le traitement de l'uremie
IE852596L (en) Peptides active on the cns
BR9104997A (pt) Complexos ligados em ponte a hidrogenio,processo para sua preparacao farmaceutica
KR890701545A (ko) 건선치료를 위한 제약학적 조성물
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
ES2072244T1 (es) Compuestos y productos de reaccion de amadori, procedimiento para su fabricacion y uso de los mismos.
IT1250636B (it) Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
GR3001922T3 (en) Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration
Nettelbladt et al. Amino-acid content of serum in rheumatoid arthritis
KR910009267A (ko) 우울증의 치료방법
JO1195B1 (en) Pharmaceutical preparations for the treatment of cyanosis and ocular hypertension
ATE92078T1 (de) Pharmakologisch aktive peptide.
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도
JPS5668374A (en) Food composition for hepatic insufficiency
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
RU92001485A (ru) Лекарственное средство для парентерального питания и дезинтоксикации
CA2099529A1 (en) Antemortem nutrient supplement for livestock
KR890000399A (ko) (e)-2-(p-플루오로펜에틸)-3-플루오로알릴아민
ATE70454T1 (de) Vincristin enthaltendes produkt.
FI943733A0 (fi) Amadori-reaktioyhdisteet ja -tuotteet, menetelmä niiden valmistamiseksi sekä niiden käyttö